- Trial ID:
- Thomas Heywood
Inclusion Criteria: - The patient is 18 to 80 years of age, inclusive; both men and women will be enrolled. - The patient has a diagnosis of chronic HF of ischemic or nonischemic etiology for at least 6 months - The patient is on stable, optimally tolerated dosages of HF therapies including beta-blockers (approved for country-specific usage), angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), and/or aldosterone antagonists, without change in dose for at least 1 month before study intervention - The patient is on a stable, outpatient, oral diuretic dosing regimen in which the patient remains clinically stable during screening. - Other Criteria apply, please contact the investigator Exclusion Criteria: - The patient has NYHA Functional Class I or Functional Class IV symptoms. - Other Criteria apply, please contact the investigator
Why isn't this trial accepting new patients?
The trial may have a limited enrollment number, reached its maximum, or come to the end of its enrollment period. View trials that are recruiting
How else can Scripps help me?
We have a broad range of physician expertise and specialized medical services available. You can find a doctor online, call 1-800-SCRIPPS (1-800-727-4777) for personal help, or see related Scripps services.
How can I find trials that are accepting new participants?
For more information, see a list of trials that are recruiting, or call the clinical research office at 858-648-6402 for help.